BMJ (Clinical research

ed) 2010;340:c2096 CrossRef 3 Ka

BMJ (Clinical research

ed). 2010;340:c2096.CrossRef 3. Karras D. Antibiotic misuse in the emergency department. Acad Emerg Med. 2006;13(3):331–3.PubMedCrossRef 4. Chin MH, Wang LC, Jin L, Mulliken R, Walter J, Hayley DC, et al. Appropriateness Selumetinib nmr of medication selection for older persons in an urban academic emergency department. Acad Emerg Med. 1999;6(12):1232–42.PubMedCrossRef 5. National Research Council. Hospital-based emergency care: at the breaking point. Washington, DC: The National Academies Press; 2007. 6. Hafner JW Jr, Belknap SM, Squillante MD, Bucheit KA. Adverse drug events in emergency department patients. Ann Emerg Med. 2002;39(3):258–67.PubMedCrossRef 7. Niska R, Bhuiya F, Xu J. National Hospital Ambulatory Medical Care Survey: 2007 Emergency Department Summary. National Health Statistics Reports; no 26. National Center for Health Statistics; 2010. 8. Micek ST, Welch EC, Khan J, Pervez M, Doherty JA, Reichley RM, et al. Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with Gram-negative bacteremia.

J Hosp Med. 2011;6(7):405–10.PubMedCrossRef 9. Ramphal R. Importance of adequate initial antimicrobial therapy. Chemotherapy. 2005;51(4):171–6.PubMedCrossRef 10. May L, Cosgrove S, L’Archeveque M, Talan DA, Payne P, Jordan J, et al. A call to action for antimicrobial stewardship in the emergency department: approaches and strategies. Ann Emerg Med. 2013;62(1):69–77.e2.PubMedCrossRef Selleck Adriamycin 11. ASHP statement on pharmacy services to the emergency department. Am J Health Syst Pharm. 2008;65:2380–83. 12. ASHP statement on the pharmacist’s role in antimicrobial stewardship and infection prevention and control. Am J Health Syst Pharm. 2010;67(7):575–7. 13. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, et al. Infectious

Diseases Society Cyclin-dependent kinase 3 of selleck inhibitor America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–77.PubMedCrossRef 14. Baker SN, Acquisto NM, Ashley ED, Fairbanks RJ, Beamish SE, Haas CE. Pharmacist-managed antimicrobial stewardship program for patients discharged from the emergency department. J Pharm Pract. 2012;25(2):190–4.PubMedCentralPubMedCrossRef 15. Randolph TC, Parker A, Meyer L, Zeina R. Effect of a pharmacist-managed culture review process on antimicrobial therapy in an emergency department. Am J Health Syst Pharm. 2011;68(10):916–9.PubMedCrossRef 16. Rynn KO, Hughes FL. Development of a culture review follow-up program in the emergency department. ACCP Conference Abstract No. 292. Pharmacotherapy. 2001;21(10):1299. 17. Wymore ES, Casanova TJ, Broekemeier RL, Martin JK, Jr. Clinical pharmacist’s daily role in the emergency department of a community hospital. Am J Health Syst Pharm. 2008;65(5):395–6, 8–9. 18. Lindsay P, Schull M, Bronskill S, Anderson G.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>